» Articles » PMID: 35925537

Are Ovarian Responses and the Number of Transferable Embryos Different in Females and Partners of Male Balanced Translocation Carriers?

Overview
Publisher Springer
Date 2022 Aug 4
PMID 35925537
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare ovarian response and the number of transferable embryos between women with balanced autosomal translocations and women whose partners carry the translocation (control group). To investigate the predictive value of metaphase II (MII) oocyte number and biopsied embryo number for gaining at lowest one transferable embryo.

Design: We retrospectively analyzed 1942 preimplantation genetic testing for structural rearrangements (PGT-SR) cycles of 1505 balanced autosomal translocation couples over 8 years. All cycles were divided into two subgroups: Robertsonian and reciprocal translocations (ROBT and ReBT). Receiver operator characteristic (ROC) curves were plotted to ascertain a cutoff of MII oocytes and biopsied embryos as predictors of gaining at lowest one transferable embryo.

Result: There were no statistical differences in baseline features or ovarian response indicators regarding the number of retrieved/MII oocytes, E2 level on the day of HCG, and ovarian sensitivity index (OSI) between women with balanced autosomal translocations and control group (P > 0.05). A decreased number of transferable embryos were found in women with balanced autosomal translocations regardless of the type of translocation. The cutoff values for gaining at lowest one transferable embryo are 12.5 MII oocytes and 4.5 biopsied embryos, respectively.

Conclusion: Women with balanced autosomal translocations have a normal ovarian response, but fewer transferable embryos, meaning that higher gonadotropin (Gn) doses may be required to increase transferable embryos. When fewer than 12.5 MII oocytes or 4.5 blastocysts are obtained in a PGT-SR cycle, couples should be notified that the likelihood of gaining a transferable embryo is low.

Citing Articles

Effects of chromosomal translocation characteristics on fertilization and blastocyst development - a retrospective cohort study.

Wu S, Zhang J, Guan Y, Ren B, Zhang Y, Liu X BMC Med Genomics. 2023; 16(1):273.

PMID: 37915045 PMC: 10619257. DOI: 10.1186/s12920-023-01715-4.

References
1.
Hamerton J, Canning N, Ray M, Smith S . A cytogenetic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities. Clin Genet. 1975; 8(4):223-43. DOI: 10.1111/j.1399-0004.1975.tb01498.x. View

2.
Fryns J, Van Buggenhout G . Structural chromosome rearrangements in couples with recurrent fetal wastage. Eur J Obstet Gynecol Reprod Biol. 1999; 81(2):171-6. DOI: 10.1016/s0301-2115(98)00185-7. View

3.
Scriven P . PGT-SR (reciprocal translocation) using trophectoderm sampling and next-generation sequencing: insights from a virtual trial. J Assist Reprod Genet. 2021; 38(8):1971-1978. PMC: 8417212. DOI: 10.1007/s10815-021-02174-5. View

4.
Mayeur A, Ahdad N, Hesters L, Grynberg M, Romana S, Sonigo C . Does the prognosis after PGT for structural rearrangement differ between female and male translocation carriers?. Reprod Biomed Online. 2020; 40(5):684-692. DOI: 10.1016/j.rbmo.2020.01.025. View

5.
Tong J, Niu Y, Wan A, Zhang T . Effect of parental origin and predictors for obtaining a euploid embryo in balanced translocation carriers. Reprod Biomed Online. 2021; 44(1):72-79. DOI: 10.1016/j.rbmo.2021.09.007. View